Cencora (COR)CEO sold ~$1.81M

~$1.81M

Approx. value · 5,096 sh @ $354.73

67K

Holds after · shares reported

Traded

Jan 20, 2026

Filed

Jan 23, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Dec 17, 2025InsiderOfficer sold ~$1.38M of COR shares in the open market
2. Dec 18, 2025InsiderCEO sold ~$1.75M of COR shares in the open market
3. Dec 19, 2025Insider · 2 peopleInsiders: 2 sales (~$1.7M)
4. Jan 12, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations
5. Jan 14, 2026FDARecall: Oxycodone Hydrochloride Tablets, USP (CII), 5 mg, 100-Count (10 x 10) blister cards per carton, Rx Only, The drug product contained in this package is from NDC…
6. Jan 16, 2026Federal contract · $7.7M obligatedDepartment of Defense awarded Cencora: $7.74M obligated to date
7. Jan 20, 2026 · this disclosureInsider · 13 days before resultsCEO sold ~$1.81M of COR shares in the open market

What came next

1. Jan 20, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On January 20, 2026, the Board of Directors (the “Board”) of Cencora, Inc. (the “Company”) appointed Ellen G. Cooper to serve on the Board (the “Appointment”), effective immediately.”
2. Feb 2, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
3. Feb 3, 2026Federal contract · $4.9M obligatedDepartment of Defense awarded Cencora: $4.93M obligated to date
4. Feb 13, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations (and 2 more items)
5. Feb 18, 2026Federal contract · $5.2M obligatedDepartment of Defense awarded Cencora: $5.18M obligated to date
6. Feb 18, 2026Federal contract · $4.8M obligatedDepartment of Defense awarded Cencora: $4.79M obligated to date
7. Feb 18, 2026InsiderCEO sold ~$479K of COR shares in the open market
8. Feb 20, 2026InsiderCEO sold ~$1.35M of COR shares in the open market
9. Mar 11, 2026Federal contract · $9.0M obligatedDepartment of Defense awarded Cencora: $9.01M obligated to date
10. Mar 16, 2026FDARecall: Meclizine Hydrochloride Tablets, USP 12.5 mg, (a) 50 Tablets [5 x 10] (NDC 60687-775-65) (b) 12.5 mg Individual Dose ( NDC 60687-775-11), Rx Only, Distributed…
11. Mar 17, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On March 17, 2026, Cencora, Inc. (the “Company”) announced that James F. Cleary will retire as Executive Vice President and Chief Financial Officer of the Company effective June 30, 2026.”
12. Mar 23, 2026Congress · 1 personMembers of Congress: 2 purchases
13. Mar 26, 20265% stakeThe Vanguard Group reported a passive stake (13G)
14. Mar 31, 2026CongressDisclosed purchase of COR — reported range $1,001 - $15,000
15. Apr 29, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.3%
16. May 1, 2026FDARecall: Primidone Tablets, USP, 50 mg, 100 Tablets (10 x 10 unit dose blister) per carton, Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217. Ca…
17. May 1, 2026FDARecall: Primidone Tablets, USP, 250 mg, 100 Tablets (10 x 10 unit dose blister) per carton, Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217. C…
18. May 6, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Cencora

For Cencora, OQRO holds 7 insider filings (SEC Form 4 or Form 144), 1 Congress trade report, 29 fund holdings reports (13F) and 2 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its COR page.

Other recent filings by Robert P. Mauch, President & CEO

• SEC Form 4 at Cencora (COR)Feb 25, 2026
• SEC Form 4 at Cencora (COR)Feb 21, 2026
• SEC Form 4 at Cencora (COR)Dec 23, 2025
• SEC Form 4 at Cencora (COR)Nov 20, 2025
• SEC Form 4 at Cencora (COR)Oct 22, 2025

The full history of Robert P. Mauch, President & CEO is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Cencora

• SEC Form 4Oct 5, 2026
• SEC Form 4Sep 17, 2026
• SEC Form 144Sep 16, 2026
• SEC Form 144Sep 11, 2026
• SEC Form 144Sep 4, 2026
• SEC Form 4Sep 3, 2026

Everything OQRO holds on this company is on its COR page.